Pakistan, Sept. 9 -- The vaccine, named Enteromix, is based on mRNA technology. It was created by the National Medical Research Radiology Centre and the Engelhardt Institute of Molecular Biology. The vaccine teaches the immune system to target cancer cells while leaving healthy cells untouched.Buy vitamins and supplements

Unlike chemotherapy, which can harm healthy cells, this mRNA vaccine activates a more precise immune response. It uses instructions from messenger RNA to help cells create proteins linked to cancer. These proteins help the immune system recognize and attack only the cancerous cells. This method reduces side effects and improves targeting.

Buy vitamins and supplements

The vaccine was tested on 48 patients with colon ca...